NanoCell
Intrauterine Treatment for Improving Embryo Implantation Rates
StartupNanoCell is a Rehovot-based startup in the Health Tech & Life Sciences sector, established in 2015. Intrauterine Treatment for Improving Embryo Implantation Rates. NanoCell was founded by Prof. Irit Sagi. Key investors include Arieli Group. The company has 1-10 employees. Core technologies: Materials & Substances, Implants, Composites.
The company follows a B2B business model. Product stage: R&D. The company holds 1 patent.
- StagePre-Seed
- ProductR&D
- ModelB2B
- Employees1-10
- HQRehovot
- DistrictCenter District
- Last RoundUndisclosed
- Arieli GroupLead
Prof. Irit SagiFounder
What does NanoCell do?
NanoCell is dedicated to advancing womens reproductive health through biopharmaceutical technologies. The companys proprietary intrauterine treatment significantly improves embryo implantation, thereby increasing the chances of conception. NanoCell is developing a method, kit, and composition for increasing the implantation rate of embryos in both humans and livestock using enzymatically remodeled extra-cellular matrix (ECM) to improve the efficiency of embryo implantation.
Who founded NanoCell?
NanoCell was founded in 2015 by Prof. Irit Sagi (Founder).
What sector is NanoCell in?
NanoCell operates in Health Tech & Life Sciences, Medical Devices, Medical Treatment & Therapeutics, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Materials & Substances, Implants, Composites. Target customers: Healthcare & Life Sciences, Healthcare, Providers, Consumers, Demographics & Family, Women, Agriculture & Food, Livestock.
Where is NanoCell located?
NanoCell is based in Rehovot, Israel, Center District.